Unlock stock picks and a broker-level newsfeed that powers Wall Street.

BSE - Delayed Quote INR

Orchid Pharma Limited (ORCHPHARMA.BO)

Compare
775.30
-2.05
(-0.26%)
At close: April 17 at 3:29:41 PM GMT+5:30
Loading Chart for ORCHPHARMA.BO
  • Previous Close 777.35
  • Open 788.90
  • Bid 775.65 x --
  • Ask 780.05 x --
  • Day's Range 761.75 - 798.00
  • 52 Week Range 670.05 - 1,998.00
  • Volume 6,924
  • Avg. Volume 12,587
  • Market Cap (intraday) 39.323B
  • Beta (5Y Monthly) 1.96
  • PE Ratio (TTM) 35.21
  • EPS (TTM) 22.02
  • Earnings Date May 21, 2025 - May 26, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date Sep 13, 2012
  • 1y Target Est 1,502.67

Orchid Pharma Limited, a pharmaceutical company, engages in the development, manufacture, and marketing of active pharmaceutical ingredients, bulk actives, finished dosage formulations, and nutraceuticals in India. Its active pharmaceutical ingredients product portfolio includes oral cephalosporins, injectable cephalosporins, veterinary products, and non-antibiotics. The company has multi-therapeutic presence in anti-infectives, anti-inflammatory, central nervous system, cardiovascular segment, nutraceuticals, and other oral and sterile products, as well as offers new drug discovery systems and pharmaceutical research and development services. It also exports its products to approximately 40 countries internationally. The company was formerly known as Orchid Chemicals & Pharmaceuticals Limited and changed its name to Orchid Pharma Limited in October 2015. Orchid Pharma Limited was incorporated in 1992 and is based in Narsinghpur, India. Orchid Pharma Limited operates as a subsidiary of Dhanuka Laboratories Limited.

www.orchidpharma.com

871

Full Time Employees

March 31

Fiscal Year Ends

Recent News: ORCHPHARMA.BO

View More

Performance Overview: ORCHPHARMA.BO

Trailing total returns as of 4/17/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

ORCHPHARMA.BO
57.11%
S&P BSE SENSEX (^BSESN)
0.53%

1-Year Return

ORCHPHARMA.BO
29.18%
S&P BSE SENSEX (^BSESN)
7.69%

3-Year Return

ORCHPHARMA.BO
93.00%
S&P BSE SENSEX (^BSESN)
34.65%

5-Year Return

ORCHPHARMA.BO
4,420.70%
S&P BSE SENSEX (^BSESN)
148.67%

Compare To: ORCHPHARMA.BO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ORCHPHARMA.BO

View More

Valuation Measures

Annual
As of 4/17/2025
  • Market Cap

    39.32B

  • Enterprise Value

    38.49B

  • Trailing P/E

    35.26

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    4.36

  • Price/Book (mrq)

    3.21

  • Enterprise Value/Revenue

    4.27

  • Enterprise Value/EBITDA

    24.74

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    12.30%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    9.02B

  • Net Income Avi to Common (ttm)

    1.11B

  • Diluted EPS (ttm)

    22.02

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.44B

  • Total Debt/Equity (mrq)

    13.47%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: ORCHPHARMA.BO

View More

Company Insights: ORCHPHARMA.BO

Research Reports: ORCHPHARMA.BO

View More

People Also Watch